We are live on ! Find out more
CS

Cannell & Spears Portfolio holdings

AUM $5.1B
1-Year Est. Return 31.77%
This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+31.77%
3 Year Est. Return
+94.5%
5 Year Est. Return
+108.17%
10 Year Est. Return
+357.88%
AUM
$791M
AUM Growth
+$12.6M
Cap. Flow
-$19.3M
Cap. Flow %
-2.44%
Top 10 Hldgs %
45.52%
Holding
139
New
7
Increased
27
Reduced
43
Closed
7

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$11.1M
2
KEY icon
KeyCorp
KEY
+$3.27M
3
UPS icon
United Parcel Service
UPS
+$1.06M
4
SLB icon
SLB Ltd
SLB
+$915K
5
XOM icon
ExxonMobil
XOM
+$579K

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$9.74M
2
JPM icon
JPMorgan Chase
JPM
+$9.72M
3
MET icon
MetLife
MET
+$6.47M
4
CB icon
Chubb
CB
+$4.94M
5
CVS icon
CVS Health
CVS
+$849K

Sector Composition

Rank Sector Weight
1 Financials 25.6%
2 Healthcare 19.03%
3 Technology 16.01%
4 Industrials 13.19%
5 Consumer Discretionary 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VOO icon
76
Vanguard S&P 500 ETF
VOO
$974B
$557K 0.07%
2,575
+575
+29% +$123K
BNY
77
Bank of New York Mellon
BNY
$108B
$532K 0.07%
11,262
– –
APA icon
78
APA Corp
APA
$12.4B
$498K 0.06%
9,700
– –
CL icon
79
Colgate-Palmolive
CL
$74.4B
$488K 0.06%
6,666
– –
VEU icon
80
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$480K 0.06%
10,037
+2,615
+35% +$122K
GS icon
81
Goldman Sachs
GS
$314B
$469K 0.06%
2,040
– –
BR icon
82
Broadridge
BR
$17.3B
$467K 0.06%
6,870
– –
LLY icon
83
Eli Lilly
LLY
$1.05T
$450K 0.06%
5,350
-250
-4% -$20K
INTC icon
84
Intel
INTC
$478B
$446K 0.06%
12,364
-300
-2% -$10.9K
USB icon
85
US Bancorp
USB
$98.4B
$445K 0.06%
8,650
– –
AXP icon
86
American Express
AXP
$242B
$439K 0.06%
5,552
-675
-11% -$52.8K
FSI icon
87
Flexible Solutions
FSI
$75.7M
$436K 0.06%
296,500
– –
FIS icon
88
Fidelity National Information Services
FIS
$21.7B
$430K 0.05%
5,400
– –
VWO icon
89
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$424K 0.05%
10,664
– –
QQQ icon
90
Invesco QQQ Trust
QQQ
$462B
$391K 0.05%
2,950
– –
DIS icon
91
Walt Disney
DIS
$170B
$388K 0.05%
3,424
-850
-20% -$93.6K
PFE icon
92
Pfizer
PFE
$143B
$373K 0.05%
11,500
– –
VIAB
93
DELISTED
Viacom Inc. Class B
VIAB
$371K 0.05%
7,968
– –
EG icon
94
Everest Group
EG
$15.1B
$360K 0.05%
1,539
– –
XLV icon
95
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
$360K 0.05%
4,845
-1,135
-19% -$82.7K
MA icon
96
Mastercard
MA
$480B
$339K 0.04%
3,010
+1,030
+52% +$113K
IGV icon
97
iShares Expanded Tech-Software Sector ETF
IGV
$13.8B
$335K 0.04%
13,250
-2,150
-14% -$51.8K
FSNN
98
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
$316K 0.04%
133,333
– –
BEN icon
99
Franklin Resources
BEN
$17B
$314K 0.04%
7,449
-5,442
-42% -$226K
NLY icon
100
Annaly Capital Management
NLY
$16.9B
$305K 0.04%
6,853
– –
2 3
4
5 6

Similar funds

NC
Nicholas Company Milwaukee, Wisconsin $5.1B AUM 8.43% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
VT
Vise Technologies New York $5.09B AUM 22.62% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Cannell & Spears's Q1 2017 Portfolio in Review

As of Q1 2017, Cannell & Spears held 139 positions worth $791M, up 1.6% from $779M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cannell & Spears's Q1 2017 filing shows 7 new, 27 increased, 43 reduced and 7 closed positions. Its largest new stake was KeyCorp: 178,634 shares worth $3.18M. The largest sale was Thermo Fisher Scientific, an estimated $9.74M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 29% a quarter earlier, followed by Healthcare and Technology.

  • Cannell & Spears's largest Q1 2017 buy was KeyCorp: 178,634 shares worth $3.18M.
  • Cannell & Spears added most to Gilead Sciences in Q1 2017, an estimated $11.1M increase.
  • Cannell & Spears's biggest Q1 2017 reduction was Thermo Fisher Scientific, cutting an estimated $9.74M.
  • Cannell & Spears fully exited Kimberly-Clark in Q1 2017, selling an estimated $604K.
  • Cannell & Spears's ten largest holdings make up 46% of its $791M portfolio in Q1 2017.
  • Cannell & Spears opened 7 new positions and closed 7 in Q1 2017.
  • Cannell & Spears's portfolio value rose 1.6% quarter-over-quarter to $791M.

Based on Cannell & Spears's 13F filing for Q1 2017, filed 10 May 2017.